By identifying which patents are being aggressively enforced and forecasting when approved generics will enter the market (signaling the end of a shortage), pharmacies can make informed decisions about which products to compound and when to exit the market to avoid liability.41 Works cited A Pharma Execs Guide to Preliminary Freedom-to-Operate Analysis DrugPatentWatch, accessed December 19, 2025, Breaking Down Patent Barriers: A Guide for Compounding Pharmacies DrugPatentWatch, accessed December 19, 2025, 503A vs
Diabetes care portfolio including GLP-1 receptor agonist therapies
He attributed the under-prescribing to several forces: specialty silos that still treat these as diabetes drugs, despite a JAMA Cardiology review urging cardiologists to begin prescribing them directly
Since hitting the mainstream in 2023, people have been discovering and reporting a whole number of bizarre side effects that come from taking GLP-1 medications like Ozempic and Mounjaro
Leave on for 30 minutes or until it turns clear then remove